2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Non functioning pancreatic endocrine tumor
1
Adenoma, Islet Cell
1
Interventions
Everolimus
9
Temozolomide
7
Sunitinib
7
Specimen Handling
4
Octreotide
4
Magnetic Resonance Spectroscopy
4
Fluorouracil
4
Capecitabine
4
lutetium Lu 177 dotatate
3
Leucovorin
3
sargramostim
2
montanide ISA 51
2
incomplete Freund's adjuvant
2
cabozantinib
2
Thalidomide
2
Streptozocin
2
Sorafenib
2
Oxaliplatin
2
Irinotecan
2
Injections
2
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
Doxorubicin
2
Cytoreduction Surgical Procedures
2
Colony-Stimulating Factors
2
Bevacizumab
2
surufatinib
1
sapanisertib
1
recombinant interferon alpha 2b-like protein
1
pentetreotide
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
Chromogranin A
×
Clear all
NCT02759718
2016-05-03
CgA
Asan Medical Center
Phase 4
Unknown
111 enrolled